Patent: 6,255,067

Try a free trial

See Plans and Pricing

« Back to Dashboard

Summary for Patent: 6,255,067

Title:	cDNA encoding peptidyl-glycine alpha-amidating monooxygenase (PAM)
Abstract:	The sequence of bovine PAM is taught as well as new forms of PAM not known before. One new form is membrane bound and provides the basis of methods for alpha-amidating inactive precursors of peptide hormones.
Inventor(s):	Keutmann; Henry T. (Concord, MA), Schofield; Peter (Heidelberg, DE), Rodriguez; Henry (Belmont, CA), Eipper; Betty (Baltimore, MD), Mains; Richard (Baltimore, MD)
Assignee:	The Johns Hopkins University (Baltimore, MD)
Application Number:	07/096,447
Patent Claims:	see list of patent claims

Details for Patent 6,255,067

Glossary

Subscribe to access the full database, or try a Free Trial
Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Number	Approval Date	Patent No.	Assignee	Estimated Patent Expiration	Status	Orphan	Source
Schering	INTRON A	interferon alfa-2b	VIAL	103132	001	1986-06-04	➤ Sign Up	The Johns Hopkins University (Baltimore, MD)	2037-11-19	RX		search
Schering	INTRON A	interferon alfa-2b	VIAL	103132	002	1986-06-04	➤ Sign Up	The Johns Hopkins University (Baltimore, MD)	2037-11-19	RX		search
Schering	INTRON A	interferon alfa-2b	VIAL	103132	003	1986-06-04	➤ Sign Up	The Johns Hopkins University (Baltimore, MD)	2037-11-19	RX		search
>Applicant	>Tradename	>Biologic Ingredient	>Dosage Form	>BLA	>Number	>Approval Date	>Patent No.	>Assignee	>Estimated Patent Expiration	>Status	>Orphan	>Source

International Patent Family for US Patent 6,255,067

Subscribe to access the full database, or try a Free Trial
Country	Patent Number	Publication Date
Austria	160172	Nov 15, 1997
Germany	3856069	Dec 18, 1997
European Patent Office	0382766	Aug 22, 1990
European Patent Office	0382766	Nov 12, 1997
Japan	H03501205	Mar 22, 1991
World Intellectual Property Organization (WIPO)	8902460	Mar 23, 1989
>Country	>Patent Number	>Publication Date

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

By using our website you are consenting to our use of cookies in accordance with our privacy policy.